Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

States and Lidoderm

Seven years after the Federal Trade Commission launched its antitrust suit over the delay to market of a generic version of the Lidoderm painkiller patch – and nearly a year after settling the suit for $270 million – 18 states sued Endo Pharmaceutical on Friday over the issue.

SAN FRANCISCO – Seven years after the Federal Trade Commission launched its antitrust suit over the delay to market of a generic version of the Lidoderm painkiller patch – and nearly a year after settling the suit for $270 million – 18 states sued Endo Pharmaceutical on Friday over the issue.

Categories / Business, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...